 MALVERN, Pa., April 26, 2022 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy, today announced that the company will report first quarter 2022 financial results on Tuesday, May 10, 2022. TELA Bios management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. 